Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Synthomer PLC Director's Dealing 2020

May 11, 2020

4649_dirs_2020-05-11_13f26243-07fb-45e8-a1eb-75e0aa1a0328.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 4695M

Synthomer PLC

11 May 2020

LEI: 213800EHT3TI1KPQQJ56

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 

1 Details of the person discharging managerial responsibilities / person closely associated
a) Name Calum MacLean
2 Reason for the notification
a) Position/status Chief Executive Officer
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Synthomer plc
b) LEI 213800EHT3TI1KPQQJ56
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of 10p each
Identification code GB0009887422
b) Nature of the transaction Purchase of shares using net proceeds from accrued dividends arising from the exercise on 6 May 2020 of the 2017 award granted under the 2011 Performance Share Plan
c) Price(s) and volume(s)
Price(s) Volume(s)
270.2p 1,260
d) Aggregated information
- Aggregated volume 1,260
- Price £3,404.52
e) Date of the transaction 6 May 2020
f) Place of the transaction Not applicable

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

DSHEAPSFFEAEEEA